Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 52,755 | 35,783 | 51,960 | 42,766 | 30,165 |
| Operating Income | -52,755 | -35,783 | -51,960 | -42,766 | -30,165 |
| Other Income | 451 | 200 | 174 | 184 | 210 |
| Pre-tax Income | -52,304 | -35,583 | -51,786 | -42,582 | -29,955 |
| Net Income Continuous | -52,304 | -35,583 | -51,786 | -42,582 | -29,955 |
| Net Income | $-52,304 | $-35,583 | $-51,786 | $-42,582 | $-29,955 |
| EPS Basic Total Ops | -1.01 | -0.69 | -1.02 | -0.83 | -0.58 |
| EPS Basic Continuous Ops | -1.01 | -0.69 | -1.01 | -0.83 | -0.58 |
| EPS Diluted Total Ops | -1.01 | -0.69 | -1.02 | -0.83 | -0.58 |
| EPS Diluted Continuous Ops | -1.01 | -0.69 | -1.01 | -0.83 | -0.58 |
| EBITDA(a) | $-51,889 | $-34,753 | $-50,882 | $-41,809 | $-29,262 |